This site is intended for healthcare professionals

Listen or subscribe on

This podcast series was initiated and fully funded by Sanofi. The content has been reviewed and approved by the sponsoring company and speakers prior to broadcast. Editorial support for this podcast was provided by OmniaMed Communications. GPnotebook has had no input into the content of this podcast series. © 2022 Sanofi

The challenge of managing the older person with diabetes (Promotional content from Sanofi)

Diabetes and endocrinology

18 November 2022

MAT-XU-2200512 (v1.0) I November 2022

In this podcast, Dr Amar Puttanna, Kathy Davies and Sarah Gregory will discuss some of the challenges when caring for the older person with diabetes and Sanofi’s role in supporting the care of older people with diabetes, particularly those in care homes.

UK Prescribing information for Toujeo^® (insulin glargine 300 U/mL) can be accessed by clicking here.

Republic of Ireland Prescribing information for Toujeo^® (insulin glargine 300 U/mL) can be accessed by clicking here.

Adverse events should be reported.

Great Britain and Northern Ireland reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events should also be reported to Sanofi Tel: 0800 090 2314. Alternatively, send via email to [email protected].

Republic of Ireland reporting forms and information can be found at www.hpra.ie; email: [email protected]. Adverse events should also be reported to Sanofi Ireland Ltd. Tel: 01 403 5600. Alternatively, send via email to [email protected].